ASCITES HEPATIC
Clinical trials for ASCITES HEPATIC explained in plain language.
Never miss a new study
Get alerted when new ASCITES HEPATIC trials appear
Sign up with your email to follow new studies for ASCITES HEPATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug shows promise for liver cirrhosis fluid
Disease control OngoingThis study looks at whether a type of diabetes medicine called SGLT-2 inhibitors can help control ascites (fluid buildup in the belly) in people with liver cirrhosis and type 2 diabetes. About 40 adults with moderate liver disease will either receive the drug plus standard care, …
Matched conditions: ASCITES HEPATIC
Sponsor: University of Palermo • Aim: Disease control
Last updated May 17, 2026 05:20 UTC
-
New hope for deadly Liver-Kidney complication
Disease control OngoingThis study is testing whether a drug called ambrisentan can help people with hepatorenal syndrome, a serious kidney complication that occurs in advanced liver cirrhosis and often leads to death. Researchers are comparing ambrisentan against the standard treatment, terlipressin, i…
Matched conditions: ASCITES HEPATIC
Phase: PHASE2 • Sponsor: Noorik Biopharmaceuticals AG • Aim: Disease control
Last updated Apr 16, 2026 13:02 UTC